what is glp-1 for vs. GLP-1 + GIP: What's the Difference your Metabolism? GLP-1 actions and target organs.
Description
and with patients who have taken GLP-1 drugs and experienced widely varying reactions.
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.
Michael Greger explores the science behind these medications and gives us the answers we need
A new Stanford-led study suggests up to 10% of people may be genetically resistant to GLP-1 drugs like Ozempic and Wegovy
What makes a weight loss program one of the best
